International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
← All news
Funding and awards

$1.3 million co-investment from Canada's Digital Technology Supercluster for a COVID-19 prediction tool

Toronto. In June 2020, 16 Bit led a project funded by the Digital Technology Supercluster's COVID-19 program to build an AI tool predicting which hospitalized COVID-19 patients would need intensive care or ventilation, with Sunnybrook, Trillium Health Partners, Layer 6, SofTx Innovations, Roche and the Vector Institute.

The project combined clinical data from COVID-19 inpatients at two Ontario hospitals to flag early signs of a severe course. It was 16 Bit’s first large collaborative project with hospital partners, and the Sunnybrook relationship it built carried into the Rho deployments that followed. The COVID-19 tool was a research project, not a commercial product.